Post Categories
Mental Vacation
August 11, 2015
Need a vacation? Don’t have time? Spend the next 45 seconds pretending you’re here….
Fast Track Routes for Medicines that address Unmet Medical Needs
July 27, 2015
Launch of two-month public consultations on revised guidelines on accelerated assessment and conditional marketing authorization The European Medicines Agency (EMA) has revised its guidelines…
Sports Nutrition Leadership, Benchtop to Countertop: Watch the Webinar on Building Better Beverages with panelist Doug Kalman, Director of Nutrition & Endocrinology at QPS MRA
July 29, 2015
Finding something tasty to drink at the mini-mart has gotten really complicated lately. Knowing the usual soft drinks are unhealthy, you may be tempted…
DMPK scientists from Exelixis and QPS publish on “Metabolism and Disposition of Cabozantinib in Healthy Male Volunteers and Pharmacologic Characterization of Its Major Metabolites” in DMD
July 27, 2015
Read the original Exelexis-supported publication in Drug Metabolism & Disposition (DMD). Cabozantinib (COMETRIQ®) inhibits the activity of tyrosine kinases including MET, VEGFRs and RET….
Dr. Diane Krieger from QPS MRA acknowledged in NEJM for her role as investigator in the SCALE Obesity and Prediabetes Study Group
July 27, 2015
The sheer abundance of diet drugs available suggests two things: 1) there is a huge market for them and 2) none of them work…
Hop on the QPS Bioanalysis Bus: Protein Quantitation by LC-MS/MS is Just Around the Corner
July 24, 2015
We love it when you notice! At the recent Sciex Users gathering of MS geeks in the 63th ASMS Annual Conference, one member of…
Regulatory Expertise Now Part of QPS Clinical Development Offerings
July 9, 2015
In July 2015, regulatory expert Patricia Baede joined QPS’ clinical development teams. With 20 years of experience in clinical trial conduct and all regulatory…
COVID-19 and Data: Will We Apply the Lessons Learned?
July 25, 2022
On March 11, 2020, the World Health Organization announced that COVID-19 had reached pandemic status, and people around the globe struggled to understand the…
Back in Black: Understanding the Origins of the “Original Pandemic”
July 21, 2022
In a time when news headlines, academic journals, and science websites sharing the latest discoveries and theories about SARS-CoV-2 and its many variants demand…
Changing Our Perspective on “Mind-Altering” Drugs – Part II
July 19, 2022
Developing an effective and safe medicine is a labor of love in any therapeutic area, but perhaps none so much as the central nervous…
Brain Implant Enables Communication in ALS Patient
June 29, 2022
As many as 30,000 people in the United States are currently diagnosed with amyotrophic lateral sclerosis, or ALS. This debilitating neurological condition is caused…
Changing Our Perspective on “Mind-Altering” Drugs – Part I
June 28, 2022
For a generation that grew up with “Just Say No” as a recurring theme, the idea of taking psychedelics with nicknames such as acid…
New Obesity Drug Shows Great Promise in Phase III Trials
June 22, 2022
Danish pharmaceutical giant Novo Nordisk changed the game last year, presenting data that suggested one of the company’s diabetes drugs was also highly effective…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
